State of Wyoming’s Kyntra Bio KYNB Stock Holding History

State of Wyoming’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	-$1K	–	1660
2022 Q2	$1K	Buy	2 +1	+100%	+$255	﹤0.01%	1808
2022 Q1	$0	Buy	+1	New	+$349	﹤0.01%	1867

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

State of Wyoming's KYNB Position: Q3 2022 in Review

State of Wyoming sold out of Kyntra Bio (KYNB) in Q3 2022, closing a stake of 2 shares — an estimated $1K sold.

State of Wyoming first reported a position in KYNB in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 152 funds tracked by Wall St. Rank hold KYNB as of Q3 2022.

State of Wyoming reported no remaining Kyntra Bio position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 2 Kyntra Bio shares in Q3 2022, an estimated $1K.
State of Wyoming first reported a position in Kyntra Bio in Q1 2022 and held it in 2 quarters.
State of Wyoming's Kyntra Bio position peaked at $1K in Q2 2022.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.